Dermapharm
DMP.F
#4212
Rank
โ‚น180.25 B
Marketcap
โ‚น3,272
Share price
2.06%
Change (1 day)
-9.98%
Change (1 year)

Revenue for Dermapharm (DMP.F)

Revenue in 2024 (TTM): โ‚น101.68 Billion

According to Dermapharm's latest financial reports the company's current revenue (TTM ) is โ‚น103.04 Billion. In 2023 the company made a revenue of โ‚น102.56 Billion an increase over the revenue in the year 2022 that were of โ‚น89.28 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Dermapharm from 2017 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚น101.68 B-0.86%
2023 โ‚น102.56 B14.87%
2022 โ‚น89.28 B9.51%
2021 โ‚น81.53 B21.01%
2020 โ‚น67.37 B20.52%
2019 โ‚น55.90 B18.71%
2018 โ‚น47.09 B37.73%
2017 โ‚น34.19 B